Investor Relations | Clinical Mitral Valve Regurgitation and Prolapse Repair Contact Us | Site Map
Tricuspid Valve and Mitral Valve Regurgitation treatment and repair

Disease

Treatment

Technology

News/Events

MiCardia Corporation is an early-stage venture dedicated to designing, developing and commercializing minimally invasive methods of mitral and tricuspid valve treatment. Formed in November 2004, MiCardia has been dedicated to developing treatments for Mitral Regurgitation (MR) Recurrence, Tricuspid Regurgitation Recurrence, Mitral Valve Prolapse, Ischemic Heart Disease and Congestive Heart Failure (CHF).

Since its inception, the company has built an experienced technical and clinical team, while creating a comprehensive intellectual property portfolio. Proof of concept has been completed for a Dynamically Activated Annuloplasty Ring with novel methods for off-pump intra-operative and chronic percutaneous activation methods.

Annuloplasty Ring - Mitral Valve Repair for prolapse and regurgitation

Caution: The MiCardia Dynamic Annuloplasty System is presently not available for sale.

MiCardia and the MiCardia logo are trademarks of MiCardia Corporation, registered in the United States.

AD4-0003 REV01 DC0271